European consensus proposal for immunoglobulin therapies

The use of immunoglobulin (Ig) preparations (intravenous, IVIg, subcutaneous, SCIg) for replacement and immunomodulation therapy worldwide has tripled in the past 20 years and represents an ever‐increasing cost factor for healthcare organizations. The limited access to the starting material of this...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2014-08, Vol.44 (8), p.2207-2214
Main Authors: Sewell, W. A. Carrock, Kerr, Jacqueline, Behr‐Gross, Marie‐Emmanuelle, Peter, Hans‐Hartmut
Format: Article
Language:English
Subjects:
Antibodies
Consensus
Europe
Humans
Immunization, Passive - methods
Immunization, Passive - standards
Immunodeficiencies
Immunoglobulins
Immunoglobulins - therapeutic use
Immunopathology
Immunotherapy
Medical research
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of immunoglobulin (Ig) preparations (intravenous, IVIg, subcutaneous, SCIg) for replacement and immunomodulation therapy worldwide has tripled in the past 20 years and represents an ever‐increasing cost factor for healthcare organizations. The limited access to the starting material of this essential medicinal product is currently the driving force for human plasma collection. Increasing awareness and improved diagnosis of human primary immunodeficiencies and a broadening of immunomodulatory indications are responsible for this development, and on a longer run might lead to plasma supply shortages. Consensus recommendations for the optimal use of Ig in clinical practice, including priority rankings for the most urgent indications, are therefore urgently needed. During a recent meeting in Kreuth, Germany, expert nominees from 36 Council of Europe states, together with colleagues from observer countries and regulatory agencies came up with this consensus statement.
ISSN:0014-2980
1521-4141
DOI:10.1002/eji.201444700